{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:24:00Z","timestamp":1790673840193,"version":"4.1.0"},"reference-count":43,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.24483","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T11:11:58Z","timestamp":1631099518000},"page":"e2124483","source":"Crossref","is-referenced-by-count":24,"title":["Association of COVID-19 Lockdown With the Tumor Burden in Patients With Newly Diagnosed Metastatic Colorectal Cancer"],"prefix":"10.1001","volume":"4","author":[{"given":"Alain R.","family":"Thierry","sequence":"first","affiliation":[{"name":"Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U1194, Universit\u00e9 de Montpellier, Institut R\u00e9gional du Cancer de Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brice","family":"Pastor","sequence":"additional","affiliation":[{"name":"Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U1194, Universit\u00e9 de Montpellier, Institut R\u00e9gional du Cancer de Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Pisareva","sequence":"additional","affiliation":[{"name":"Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U1194, Universit\u00e9 de Montpellier, Institut R\u00e9gional du Cancer de Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Ghiringhelli","sequence":"additional","affiliation":[{"name":"Centre Georges Fran\u00e7ois Leclerc, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bouch\u00e9","sequence":"additional","affiliation":[{"name":"H\u00f4pital Robert Debr\u00e9, Reims, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"De La Fouchardi\u00e8re","sequence":"additional","affiliation":[{"name":"Centre L\u00e9on B\u00e9rard, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Vanbockstael","sequence":"additional","affiliation":[{"name":"Institut de Canc\u00e9rologie de l'Ouest, Angers, Saint-Herblain, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Smith","sequence":"additional","affiliation":[{"name":"H\u00f4pital Haut-L\u00e9v\u00eaque, Centre Hospitalier Universitaire (CHU) de Bordeaux, Pessac, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Fran\u00e7ois","sequence":"additional","affiliation":[{"name":"Centre Antoine Lacassagne, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Dos Santos","sequence":"additional","affiliation":[{"name":"Centre Fran\u00e7ois Baclesse, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Botsen","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Godinot Institute, Reims, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Ellis","sequence":"additional","affiliation":[{"name":"Centre Catalan d'Oncologie, Perpignan, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Fonck","sequence":"additional","affiliation":[{"name":"Institut Bergoni\u00e9, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Andr\u00e9","sequence":"additional","affiliation":[{"name":"H\u020fpital Saint-Antoine, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Guardiola","sequence":"additional","affiliation":[{"name":"Centre de Canc\u00e9rologie du grand Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiza","family":"Khemissa","sequence":"additional","affiliation":[{"name":"Centre Hospitalier de Perpignan, Perpignan, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Linot","sequence":"additional","affiliation":[{"name":"H\u00f4pital Priv\u00e9 du Confluent, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Martin-Babau","sequence":"additional","affiliation":[{"name":"Centre Cario, Plerin, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Rinaldi","sequence":"additional","affiliation":[{"name":"H\u00f4pital Europ\u00e9en de Marseille, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Assenat","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, St Eloi University Hospital, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Clavel","sequence":"additional","affiliation":[{"name":"H\u00f4pital Priv\u00e9 Jean Mermoz, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Dominguez","sequence":"additional","affiliation":[{"name":"H\u00f4pital Saint Vincent de Paul, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Gavoille","sequence":"additional","affiliation":[{"name":"Institue de Canc\u00e9rologie de Lorraine, Vadoeuvre-les-Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sefrioui","sequence":"additional","affiliation":[{"name":"CHU de Rouen, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Pezzella","sequence":"additional","affiliation":[{"name":"Unicancer, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Mollevi","sequence":"additional","affiliation":[{"name":"Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U1194, Universit\u00e9 de Montpellier, Institut R\u00e9gional du Cancer de Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ychou","sequence":"additional","affiliation":[{"name":"Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U1194, Universit\u00e9 de Montpellier, Institut R\u00e9gional du Cancer de Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Mazard","sequence":"additional","affiliation":[{"name":"Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U1194, Universit\u00e9 de Montpellier, Institut R\u00e9gional du Cancer de Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,9,8]]},"reference":[{"issue":"6","key":"zoi210714r1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s43018-020-0074-y","article-title":"The impact of the COVID-19 pandemic on cancer care.","volume":"1","author":"Richards","year":"2020","journal-title":"Nat Cancer"},{"issue":"1","key":"zoi210714r3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41571-020-00446-0","article-title":"Consequences of COVID-19 for cancer care\u2014a CRUK perspective.","volume":"18","author":"Greenwood","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"zoi210714r4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1136\/jclinpath-2020-206833","article-title":"Cancer diagnostic rates during the 2020 \u2018lockdown\u2019, due to COVID-19 pandemic, compared with the 2018-2019: an audit study from cellular pathology.","volume":"74","author":"De Vincentiis","year":"2021","journal-title":"J Clin Pathol"},{"issue":"8","key":"zoi210714r5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.17267","article-title":"Changes in the number of US patients with newly identified cancer before and during the coronavirus disease 2019 (COVID-19) pandemic.","volume":"3","author":"Kaufman","year":"2020","journal-title":"JAMA Netw Open"},{"key":"zoi210714r6","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2020-000826","article-title":"ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancer.","volume":"5","author":"Vecchione","year":"2020","journal-title":"ESMO Open"},{"issue":"11","key":"zoi210714r7","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nrc1739","article-title":"Biomarkers in cancer staging, prognosis and treatment selection.","volume":"5","author":"Ludwig","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"zoi210714r8","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10555-016-9629-x","article-title":"Origins, structures, and functions of circulating DNA in oncology.","volume":"35","author":"Thierry","year":"2016","journal-title":"Cancer Metastasis Rev"},{"issue":"4","key":"zoi210714r9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nrc.2017.7","article-title":"Liquid biopsies come of age: towards implementation of circulating tumour DNA.","volume":"17","author":"Wan","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"zoi210714r10","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2012.45.2011","article-title":"Liquid biopsies: genotyping circulating tumor DNA.","volume":"32","author":"Diaz","year":"2014","journal-title":"J Clin Oncol"},{"issue":"1","key":"zoi210714r11","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1158\/1535-7163.MCT-17-1298","article-title":"Monitoring tumor burden in response to FOLFIRINOX chemotherapy via profiling circulating cell-free DNA in pancreatic cancer.","volume":"18","author":"Wei","year":"2019","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"zoi210714r12","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12916-018-1157-9","article-title":"Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection.","volume":"16","author":"Fiala","year":"2018","journal-title":"BMC Med"},{"issue":"1","key":"zoi210714r13","doi-asserted-by":"publisher","first-page":"13809","DOI":"10.1038\/s41598-020-70526-9","article-title":"Circulating cell-free DNA level predicts all-cause mortality independent of other predictors in the Health 2000 survey.","volume":"10","author":"Kananen","year":"2020","journal-title":"Sci Rep"},{"issue":"16","key":"zoi210714r14","doi-asserted-by":"publisher","first-page":"4578","DOI":"10.1158\/1078-0432.CCR-17-0232","article-title":"Circulating DNA demonstrates convergent evolution and common resistance mechanisms during treatment of colorectal cancer.","volume":"23","author":"Thierry","year":"2017","journal-title":"Clin Cancer Res"},{"key":"zoi210714r15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3389\/fonc.2018.00275","article-title":"The use of circulating tumor DNA for prognosis of gastrointestinal cancers.","volume":"8","author":"Saluja","year":"2018","journal-title":"Front Oncol"},{"issue":"1","key":"zoi210714r16","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1186\/s12885-020-07516-7","article-title":"Role of circulating free DNA in evaluating clinical tumor burden and predicting survival in Chinese metastatic colorectal cancer patients.","volume":"20","author":"Xu","year":"2020","journal-title":"BMC Cancer"},{"issue":"12","key":"zoi210714r17","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1158\/1078-0432.CCR-15-0297","article-title":"Circulating DNA as a strong multimarker prognostic tool for metastatic colorectal cancer patient management care.","volume":"22","author":"El Messaoudi","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"11","key":"zoi210714r18","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1136\/gutjnl-2016-313372","article-title":"Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer.","volume":"67","author":"Barault","year":"2018","journal-title":"Gut"},{"issue":"1","key":"zoi210714r19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/0284186X.2016.1253861","article-title":"Methodological, biological and clinical aspects of circulating free DNA in metastatic colorectal cancer.","volume":"56","author":"Spindler","year":"2017","journal-title":"Acta Oncol"},{"issue":"7","key":"zoi210714r20","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/annonc\/mdz139","article-title":"Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy.","volume":"30","author":"Hamfjord","year":"2019","journal-title":"Ann Oncol"},{"issue":"12","key":"zoi210714r21","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies.","volume":"12","author":"von Elm","year":"2014","journal-title":"Int J Surg"},{"issue":"4","key":"zoi210714r22","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/nm.3511","article-title":"Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA.","volume":"20","author":"Thierry","year":"2014","journal-title":"Nat Med"},{"issue":"9","key":"zoi210714r23","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1093\/annonc\/mdx330","article-title":"Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment.","volume":"28","author":"Thierry","year":"2017","journal-title":"Ann Oncol"},{"issue":"5","key":"zoi210714r24","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1373\/clinchem.2018.298323","article-title":"Guidelines for the preanalytical conditions for analyzing circulating cell-free DNA.","volume":"65","author":"Meddeb","year":"2019","journal-title":"Clin Chem"},{"issue":"5","key":"zoi210714r25","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.molonc.2014.02.005","article-title":"Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancer.","volume":"8","author":"Mouliere","year":"2014","journal-title":"Mol Oncol"},{"issue":"9","key":"zoi210714r26","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1634\/theoncologist.2011-0039","article-title":"Simplified prognostic model in patients with oxaliplatin-based or irinotecan-based first-line chemotherapy for metastatic colorectal cancer: a GERCOR study.","volume":"16","author":"Chibaudel","year":"2011","journal-title":"Oncologist"},{"key":"zoi210714r27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejca.2018.03.026","article-title":"Reporting of patient characteristics and stratification factors in phase 3 trials investigating first-line systemic treatment of metastatic colorectal cancer: a systematic review.","volume":"96","author":"Goey","year":"2018","journal-title":"Eur J Cancer"},{"issue":"2","key":"zoi210714r29","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1002\/onco.v26.2","article-title":"Dramatic changes in oncology care pathways during the COVID-19 pandemic: the French ONCOCARE-COV Study.","volume":"26","author":"Brugel","year":"2021","journal-title":"Oncologist"},{"issue":"6","key":"zoi210714r30","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S1470-2045(20)30265-5","article-title":"Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands.","volume":"21","author":"Dinmohamed","year":"2020","journal-title":"Lancet Oncol"},{"issue":"5","key":"zoi210714r31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s43018-020-0065-z","article-title":"Crowdsourcing a crisis response for COVID-19 in oncology.","volume":"1","author":"Desai","year":"2020","journal-title":"Nat Cancer"},{"issue":"7","key":"zoi210714r32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236860","article-title":"Estimation of COVID-19 spread curves integrating global data and borrowing information.","volume":"15","author":"Lee","year":"2020","journal-title":"PLoS One"},{"key":"zoi210714r33","doi-asserted-by":"crossref","first-page":"m4087","DOI":"10.1136\/bmj.m4087","article-title":"Mortality due to cancer treatment delay: systematic review and meta-analysis.","volume":"371","author":"Hanna","year":"2020","journal-title":"BMJ"},{"issue":"8","key":"zoi210714r34","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/S1470-2045(20)30392-2","article-title":"Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study.","volume":"21","author":"Sud","year":"2020","journal-title":"Lancet Oncol"},{"issue":"8","key":"zoi210714r35","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1470-2045(20)30388-0","article-title":"The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study.","volume":"21","author":"Maringe","year":"2020","journal-title":"Lancet Oncol"},{"issue":"11","key":"zoi210714r36","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-043828","article-title":"Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study.","volume":"10","author":"Lai","year":"2020","journal-title":"BMJ Open"},{"issue":"6497","key":"zoi210714r37","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1126\/science.abd3377","article-title":"COVID-19 and cancer.","volume":"368","author":"Sharpless","year":"2020","journal-title":"Science"},{"issue":"9454","key":"zoi210714r38","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0140-6736(05)17706-X","article-title":"Colorectal cancer.","volume":"365","author":"Weitz","year":"2005","journal-title":"Lancet"},{"issue":"15","key":"zoi210714r39","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.2217\/fon-2018-0785","article-title":"Value of tumor size as a prognostic factor in metastatic colorectal cancer patients after chemotherapy: a population-based study.","volume":"15","author":"Yan","year":"2019","journal-title":"Future Oncol"},{"issue":"1","key":"zoi210714r40","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.1038\/s41598-019-41593-4","article-title":"Quantifying circulating cell-free DNA in humans.","volume":"9","author":"Meddeb","year":"2019","journal-title":"Sci Rep"},{"issue":"12","key":"zoi210714r41","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1002\/mc.v59.12","article-title":"Diagnostic potential of circulating cell-free nuclear and mitochondrial DNA for several cancer types and nonmalignant diseases: a study on suspected cancer patients.","volume":"59","author":"Sundquist","year":"2020","journal-title":"Mol Carcinog"},{"key":"zoi210714r42","first-page":"1","article-title":"Early detection of cancer using circulating tumor DNA: biological, physiological and analytical considerations.","author":"Bronkhorst","year":"2019","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"18","key":"zoi210714r43","article-title":"Machine learning-assisted evaluation of circulating DNA quantitative analysis for cancer screening.","volume":"7","author":"Tanos","year":"2020","journal-title":"Adv Sci (Weinh)"},{"key":"zoi210714r2","unstructured":"Uzzo? RG, Kutinov? A, Geynisman? DM. COVID-19: cancer screening, diagnosis, post-treatment surveillance in uninfected patients during the pandemic and issues related to COVID-19 vaccination in cancer patients. Accessed October 9, 2020. https:\/\/www.uptodate.com\/contents\/coronavirus-disease-2019-covid-19-cancer-screening-diagnosis-treatment-and-posttreatment-surveillance-in-uninfected-patients-during-the-pandemic"},{"key":"zoi210714r28","unstructured":"Daly N. Cancer tests and operations dropped up to 50 per cent during April lockdown, data shows. Accessed September 14, 2020. https:\/\/www.abc.net.au\/news\/2020-09-14\/cancer-tests-operations-drop-up-to-50-per-cent-april-coronavirus\/12622396"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2784019\/thierry_2021_oi_210714_1630529405.06213.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T11:12:28Z","timestamp":1631099548000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2784019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,8]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.24483","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.03.17.21253408","asserted-by":"object"}]},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,8]]}}}